Iterum Therapeutics plc (NASDAQ:ITRM) Q2 2025 Earnings Call Transcript August 5, 2025
Iterum Therapeutics plc misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.13.
Operator: Good morning. Thank you for attending today’s Iterum Therapeutics Second Quarter 2025 Financial Results and Business Update Call. My name is Megan, and I’ll be your moderator for today. [Operator Instructions] I would now like to pass the conference over to Kevin Dalton, Senior Director,...
